Sergey Mosolov

2.9k total citations · 1 hit paper
106 papers, 2.0k citations indexed

About

Sergey Mosolov is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Sergey Mosolov has authored 106 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Psychiatry and Mental health, 21 papers in Clinical Psychology and 18 papers in Pharmacology. Recurrent topics in Sergey Mosolov's work include Bipolar Disorder and Treatment (38 papers), Schizophrenia research and treatment (26 papers) and Treatment of Major Depression (18 papers). Sergey Mosolov is often cited by papers focused on Bipolar Disorder and Treatment (38 papers), Schizophrenia research and treatment (26 papers) and Treatment of Major Depression (18 papers). Sergey Mosolov collaborates with scholars based in Russia, United States and Switzerland. Sergey Mosolov's co-authors include Charles L. Bowden, Eduard Vieta, Jules Angst, Allan H. Young, Giulio Perugi, Andreev Bv, Ferenc Martényi, Darryle D. Schoepp, Bryan G. Johnson and Smulevich Ab and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Journal of Affective Disorders.

In The Last Decade

Sergey Mosolov

95 papers receiving 2.0k citations

Hit Papers

Activation of mGlu2/3 receptors as a new approach to trea... 2007 2026 2013 2019 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
    2007 790 citations Andreev Bv, Sergey Mosolov et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergey Mosolov Russia 22 1.1k 609 437 412 337 106 2.0k
Andreas Erfurth Germany 27 1.3k 1.2× 556 0.9× 313 0.7× 488 1.2× 444 1.3× 139 2.6k
Thomas J. Raedler Germany 21 946 0.9× 667 1.1× 534 1.2× 475 1.2× 223 0.7× 46 2.5k
Ferenc Martényi United States 16 561 0.5× 641 1.1× 470 1.1× 347 0.8× 310 0.9× 43 1.8k
Suresh Sundram Australia 26 608 0.6× 687 1.1× 518 1.2× 287 0.7× 447 1.3× 101 2.2k
Fernando Caravaggio Canada 26 1.0k 1.0× 549 0.9× 334 0.8× 224 0.5× 196 0.6× 98 2.3k
I. Laszlovszky Hungary 31 2.2k 2.1× 1.1k 1.8× 533 1.2× 396 1.0× 595 1.8× 96 3.1k
Bárbara Arias Spain 27 702 0.7× 570 0.9× 400 0.9× 629 1.5× 376 1.1× 86 2.2k
György Németh Hungary 25 1.6k 1.5× 449 0.7× 190 0.4× 280 0.7× 460 1.4× 86 2.1k
Ede Frecska Hungary 20 561 0.5× 539 0.9× 361 0.8× 724 1.8× 228 0.7× 80 1.8k
Carmine Tomasetti Italy 32 766 0.7× 846 1.4× 712 1.6× 653 1.6× 397 1.2× 71 2.9k

Countries citing papers authored by Sergey Mosolov

Since Specialization
Citations

This map shows the geographic impact of Sergey Mosolov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Mosolov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Mosolov more than expected).

Fields of papers citing papers by Sergey Mosolov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey Mosolov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Mosolov. The network helps show where Sergey Mosolov may publish in the future.

Co-authorship network of co-authors of Sergey Mosolov

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey Mosolov. A scholar is included among the top collaborators of Sergey Mosolov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey Mosolov. Sergey Mosolov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mosolov, Sergey, et al.. (2023). Depressive disorders and their pharmacotherapy in routine clinical practice. SHILAP Revista de lepidopterología. 15(5). 54–64. 3 indexed citations
3.
Mosolov, Sergey, et al.. (2022). The risk of developing cardiovascular disease in bipolar disorder. Biological factors and therapy. Terapevticheskii arkhiv. 94(4). 579–583. 4 indexed citations
4.
Bitter, István, Pavel Mohr, Agata Szulc, et al.. (2022). Assessment and Treatment of Negative Symptoms in Schizophrenia—A Regional Perspective. Frontiers in Psychiatry. 12. 820801–820801. 10 indexed citations
5.
Mosolov, Sergey, et al.. (2022). Patients selection for psychiatric neurosurgery: pitfalls and considerations. Progress in brain research. 272(1). 173–183. 1 indexed citations
6.
Chung, Seockhoon, et al.. (2020). STRESS AND ANXIETY AMONG HEALTHCARE WORKERS ASSOCIATED WITH COVID-19 PANDEMIC IN RUSSIA. Psychiatria Danubina. 32(3-4). 549–556. 29 indexed citations
7.
Corponi, Filippo, Gerard Anmella, Norma Verdolini, et al.. (2020). Symptom networks in acute depression across bipolar and major depressive disorders: A network analysis on a large, international, observational study. European Neuropsychopharmacology. 35. 49–60. 23 indexed citations
8.
Corponi, Filippo, Gerard Anmella, Isabella Pacchiarotti, et al.. (2020). Deconstructing major depressive episodes across unipolar and bipolar depression by severity and duration: a cross-diagnostic cluster analysis on a large, international, observational study. Translational Psychiatry. 10(1). 241–241. 9 indexed citations
9.
Mosolov, Sergey. (2020). Problems of mental health in the situation of COVID-19 pandemic. S S Korsakov Journal of Neurology and Psychiatry. 120(5). 7–7. 27 indexed citations
10.
Brancati, Giulio Emilio, Eduard Vieta, Jean‐Michel Azorin, et al.. (2019). The role of overlapping excitatory symptoms in major depression: are they relevant for the diagnosis of mixed state?. Journal of Psychiatric Research. 115. 151–157. 29 indexed citations
11.
Anmella, Gerard, Isabella Pacchiarotti, Norma Verdolini, et al.. (2019). “Do depressive and manic symptoms differentially impact on functioning in acute depression? Results from a large, cross-sectional study”. Journal of Affective Disorders. 261. 30–39. 9 indexed citations
12.
Barbuti, Margherita, Lorenzo Mazzarini, Eduard Vieta, et al.. (2019). Relationships between recurrence and polarity in major depressive disorders: Pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts. Journal of Affective Disorders. 256. 250–258. 10 indexed citations
13.
14.
Popović, Dina, Eduard Vieta, Jean‐Michel Azorin, et al.. (2015). Suicide attempts in major depressive episode: evidence from the BRIDGE‐II‐Mix study. Bipolar Disorders. 17(7). 795–803. 78 indexed citations
15.
Mosolov, Sergey, et al.. (2015). A comparative study of different types of pharmacotherapy in treatment of depressive phase of bipolar II disorder. S S Korsakov Journal of Neurology and Psychiatry. 115(1. Vyp. 2). 23–23. 3 indexed citations
16.
Mosolov, Sergey, et al.. (2014). Design and validation of standardized clinical and functional remission criteria in schizophrenia. Neuropsychiatric Disease and Treatment. 10. 167–167. 18 indexed citations
17.
18.
Mosolov, Sergey, et al.. (2008). [A comparative study of efficacy and safety of torin and zoloft].. PubMed. 108(8). 34–8.
19.
Mosolov, Sergey, et al.. (2003). [Comparative efficacy and tolerance of fluvoxamine and amitriptyline in the treatment of moderate and severe depression in mental hospital].. PubMed. 103(1). 24–9. 5 indexed citations
20.
Mosolov, Sergey, et al.. (1997). [A comparative clinico-pharmacokinetic study of the use of equivalent daily doses of lithium carbonate and Contemnol].. PubMed. 97(5). 30–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Erfurth Breakdown of academic impact, for papers by Thomas J. Raedler Breakdown of academic impact, for papers by Ferenc Martényi Breakdown of academic impact, for papers by Suresh Sundram Breakdown of academic impact, for papers by Fernando Caravaggio Breakdown of academic impact, for papers by I. Laszlovszky Breakdown of academic impact, for papers by Bárbara Arias Breakdown of academic impact, for papers by György Németh Breakdown of academic impact, for papers by Ede Frecska Breakdown of academic impact, for papers by Carmine Tomasetti
Rankless by CCL
2026